Calamos Advisors
KRMD icon

Calamos Advisors’s KORU Medical Systems KRMD Stock Holding History

Calamos Advisors’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-79,126
Closed -$342K – 1135
2026
Q1 		$342K Sell
79,126
-1,835
-2% -$9.1K ﹤0.01% 952
2025
Q4 		$470K Buy
80,961
+35,238
+77% +$169K ﹤0.01% 772
2025
Q3 		$175K Sell
45,723
-2,183
-5% -$8.35K ﹤0.01% 841
2025
Q2 		$172K Sell
47,906
-40,812
-46% -$116K ﹤0.01% 827
2025
Q1 		$225K Buy
88,718
+23,729
+37% +$88.2K ﹤0.01% 792
2024
Q4 		$250K Buy
+64,989
New +$211K ﹤0.01% 790
2020
Q3 		– Sell
-47,524
Closed -$427K – 727
2020
Q2 		$427K Buy
+47,524
New +$480K ﹤0.01% 687

Other funds holding KRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $164M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
LAM
Lakewood Asset Management Naperville, Illinois $182M AUM 22.41% 1-Year Est. Return

Calamos Advisors's KRMD Position: Q2 2026 in Review

Calamos Advisors sold out of KORU Medical Systems (KRMD) in Q2 2026, closing a stake of 79,126 shares — an estimated $342K sold.

Calamos Advisors first reported a position in KRMD in Q2 2020 and held it in 7 quarters. The position peaked at $470K in Q4 2025. 23 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • Calamos Advisors reported no remaining KORU Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Calamos Advisors sold 79,126 KORU Medical Systems shares in Q2 2026, an estimated $342K.
  • Calamos Advisors first reported a position in KORU Medical Systems in Q2 2020 and held it in 7 quarters.
  • Calamos Advisors's KORU Medical Systems position peaked at $470K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.